L&G Pharma Breakthrough UCITS ETF
ETLI.DE
#3087
ETF rank
C$27.12 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
C$18.39
Share price
-1.11%
Change (1 day)
21.89%
Change (1 year)

Expense ratio and fees for L&G Pharma Breakthrough UCITS ETF (ETLI.DE)

Total Expense Ratio

Total Expense Ratio as of November 2025: 0.49%

ter

ter as of January 2026: 0.49%